Summary of Key Points Core Viewpoint - Langzi Co., Ltd. has disclosed its total guarantee amount and financial performance, indicating significant leverage and revenue composition across its business segments [1]. Financial Guarantees - The total guarantee amount for the company and its subsidiaries is 1.906 billion yuan, with an external guarantee balance of approximately 1.129 billion yuan, representing 40.51% of the company's audited net assets for 2024 [1]. - The company has provided guarantees totaling 36 million yuan to entities outside the consolidated financial statements, accounting for 12.92% of the audited net assets for 2024 [1]. - The company has a guarantee balance of 10 million yuan for its subsidiary, Beijing Rhine Clothing Co., Ltd., which has a debt-to-asset ratio exceeding 70% [1]. Revenue Composition - For the first half of 2025, the revenue composition of Langzi Co., Ltd. is as follows: - Medical beauty accounts for 47.81% - Fashion women's wear accounts for 35.44% - Green baby products account for 15.6% - Other businesses account for 1.16% [1]. Market Capitalization - As of the report date, Langzi Co., Ltd. has a market capitalization of 7.6 billion yuan [1].

关于为全资子公司提供担保并接受关联方担保的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 证券代码：002612 证券简称：朗姿股份 公告编号：2025-060 朗姿股份有限公司 特别提示： 1、朗姿股份有限公司（以下简称"朗姿股份"或"公司"）第五届董事会 第二十九次会议和 2024 年度股东大会分别审议通过了《关于 2025 年度对外担保 额度的议案》，同意 2025 年度公司及其控股子公司的对外担保总额不超过 30.50 亿元（以下除非特别注明，所称"元"均指"人民币元"），其中对资产负债率 未超过 70%的控股子公司担保额度为 24.00 亿元，对资产负债率超过 70%的控股 子公司担保额度为 6.50 亿元。该担保额度的有效期自公司 2024 年度股东大会审 议批准本议案之日起至 2025 年度股东会召开之日止。截至本公告披露日，公司 及控股子公司对外担保总余额为 112,916 万元，占公司 2024 年度经审计净资产 的 40.51%；其中，实际被担保方北京莱茵服装有限公司资产负债率超过 70%， 公司对资产负债率超过 70%的控股子公司担 ...

证券代码：002612 证券简称：朗姿股份 公告编号：2025-061 朗姿股份有限公司 2025 年第二次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东会未出现否决提案的情形； 2、本次股东会未涉及变更以往股东会已通过的决议。 一、会议召开和出席情况 1、会议的召开情况 （1）召开时间： 现场会议时间：2025年9月29日下午14:00时 网络投票时间：通过深圳证券交易所交易系统进行网络投票的具体时间为： 2025年9月29日9:15－9:25，9:30－11:30和13:00－15:00；通过深圳证券交易所互 联网投票系统的具体时间为2025年9月29日9:15至15:00。 （2）召开地点：北京市朝阳区西大望路27号大郊亭南街3号院1号楼（朗姿 大厦）16层会议室 （3）召开方式：现场投票和网络投票相结合的方式 （5）主持人：董事长申东日先生 （4）召集人：公司董事会 （6）本次会议的召集、召开符合《公司法》《深圳证券交易所股票上市规则》 及《公司章程》等有关规定，合法有效。 2、会议的出席情况 股东出席的总 ...

1. 经公司 2025 年第一次临时股东大会审议通过的《公司章程》； 2. 公司于 2025 年 9 月 11 日在《证券时报》《上海证券报》《中国证券报》及 巨潮资讯网（http://www.cninfo.com.cn）公告的《朗姿股份有限公司第五届董事会第 三十四次会议决议公告》； 北京市金杜律师事务所 关于朗姿股份有限公司 2025 年第二次临时股东会 之法律意见书 致：朗姿股份有限公司 北京市金杜律师事务所（以下简称本所）受朗姿股份有限公司（以下简称公司） 委托，根据《中华人民共和国证券法》（以下简称《证券法》）、《中华人民共和国 公司法》（以下简称《公司法》）、中国证券监督管理委员会《上市公司股东会规则 （2025 修订）》（以下简称《股东会规则》）等中华人民共和国境内（以下简称中国 境内，为本法律意见书之目的，不包括中国香港特别行政区、中国澳门特别行政区和 中国台湾省）现行有效的法律、行政法规、规章及规范性文件和现行有效的《朗姿股 份有限公司章程》（以下简称《公司章程》）有关规定，指派律师出席了公司于 2025 年 9 月 29 日召开的 2025 年第二次临时股东会（以下简称本次股东会），并就本 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The report highlights the strong performance of the retail and beauty sectors, with a focus on the growth potential of domestic brands in the beauty industry [6][44] - The medical beauty segment is expected to see new growth drivers from innovative products, while the cosmetics sector is benefiting from the rise of domestic brands and consumer trends towards self-care [6][44] Summary by Sections 1. Market Review - The beauty and personal care index rose by 6.84% in August 2025, ranking 15th among all primary industries, underperforming the broader market which saw a 7.97% increase [12][15] - In the medical beauty sector, notable stock performances in August included Meili Tianyuan Medical Health (+32.4%), Kedi (+31.7%), and Yisi Health (+22.7%) [16] - In the cosmetics sector, leading performers were Jiaheng Home (+55.4%), Shuiyang Co. (+36.3%), and Ruoyu Chen (+29.0%) [20] 2. Medical Beauty - Jinbo Biological's "Recombinant Type III Humanized Collagen Freeze-Dried Fiber" received drug auxiliary material registration, marking a significant advancement in the medical field [26] - Longzi Co. plans to acquire 67.5% of Chongqing Milan Baiyu for 92.475 million yuan, with performance commitments ensuring net profits of at least 9.29 million yuan, 9.89 million yuan, and 11.83 million yuan from 2025 to 2027 [28] 3. Cosmetics - Proya plans to list in Hong Kong, potentially becoming the first A+H share beauty company, which would enhance its international business development [32] - Proya's investment in Huazhi Xiao will strengthen its position in the makeup sector, leveraging Huazhi Xiao's content operations and overseas channels [35] - The launch of the NAN beauty brand by Shangmei Co. represents a strategic move to enhance its presence in the mid-to-high-end market [40] 4. Investment Recommendations - The report recommends focusing on leading domestic beauty brands that are continuously evolving and capitalizing on high-growth segments [44] - Key recommendations include Shangmei Co., Maogeping, Proya, and Runben Co., with an emphasis on their strong market positions and growth potential [48]

Investment Rating - The report maintains a "Positive" outlook on the beauty and personal care industry, highlighting the resilience of domestic brands and the impact of new consumption trends [2]. Core Insights - The beauty and personal care sector experienced a robust recovery in H1 2025, with a retail sales growth of 2.9%, reversing the previous decline due to favorable consumption policies and improved income expectations [5][6]. - Domestic brands are gaining market share, with top local brands now competing closely with international counterparts, indicating a significant shift in consumer preferences [10][11]. - The report categorizes companies into three groups based on performance: those with strong brand matrices benefiting from multi-brand strategies, those capitalizing on consumer trends like domestic brands and collagen products, and those showing signs of strategic improvement [20][23]. Summary by Sections Industry Overview - The beauty market is projected to grow steadily, with a forecasted retail sales decline of 1.1% in 2024, followed by a recovery in H2 2025 [5][6]. - The domestic market share is expected to increase, with local brands achieving significant breakthroughs in both skincare and makeup segments [10][11]. Company Performance - **Cosmetics Sector**: - Major companies like Up Beauty and Proya reported revenue growth of 17.3% and 7.2% respectively in H1 2025, with net profits increasing by 30.6% and 13.8% [20][21]. - Other notable performers include Marubi and Water Sheep, with revenue growth of 30.8% and 9.0% respectively [21][22]. - **Personal Care Sector**: - Companies like Ruibin and Zhenjia showed remarkable growth, with Ruibin's revenue increasing by 67.6% and Zhenjia's by 157.11% in H1 2025 [5][20]. - **Medical Aesthetics Sector**: - Companies like Aimeike and Langzi reported mixed results, with Aimeike's revenue declining by 21.6% while Langzi's net profit surged by 64.1% [20][24]. Investment Recommendations - The report recommends investing in companies with strong brand matrices and low PE multiples, such as Up Beauty and Proya, as well as those benefiting from the Douyin traffic boost like Marubi and Water Sheep [20][24]. - It also suggests focusing on high-value segments and innovative products from brands like Ruibin and Furuida, and highlights opportunities in the maternal and infant sector with companies like Shengbeila and Haiziwang [20][24].

Group 1 - The company, Langzi Co., Ltd. (002612), reported that as of June 30, 2025, the number of shareholders is expected to reach 57,694 households [1]

Group 1 - The core viewpoint of the news is that the China-South Korea Free Trade Zone concept has experienced a decline of 2.51%, ranking among the top declines in concept sectors [1][2] - Within the China-South Korea Free Trade Zone concept, stocks such as Xinhua Jin, Lianyungang, and Langzi Co. have seen significant declines [1][2] - The main funds have net outflows of 0.96 billion yuan from the China-South Korea Free Trade Zone concept today, with nine stocks experiencing net outflows, and five stocks seeing outflows exceeding 10 million yuan [2] Group 2 - The stock with the highest net outflow is Liaoport Co., with a net outflow of 26.89 million yuan, followed by Lianyungang and Qingdao King with net outflows of 25.68 million yuan and 24.12 million yuan respectively [2] - The stocks with the highest net inflows include Xinhua Jin, with a net inflow of 13.61 million yuan, followed by Chunxue Food and Qingdao Food with net inflows of 1.99 million yuan and 0.87 million yuan respectively [2] - The table lists the stocks in the China-South Korea Free Trade Zone concept with their respective daily price changes, turnover rates, and main fund flows, highlighting the performance of individual stocks [2]

Investment Rating - The report initiates coverage with a "Buy" rating for the company Water Sheep Co., Ltd. [14] Core Insights - The cosmetics and medical beauty sector has underperformed the market, with the Shenwan Beauty Care Index declining by 2.5% from September 12 to September 19, 2025 [3][4] - The upcoming Double 11 shopping festival is expected to drive significant growth for domestic brands, with recommendations to focus on strong alpha stocks [9][10] - Water Sheep Co., Ltd. is highlighted for its dual business model of proprietary and CP brands, with stable revenue projections of 4-5 billion yuan from 2021 to 2024 and an expected gross margin of 63.01% in 2024 [10][11] Summary by Sections Industry Performance - The cosmetics and medical beauty sector has shown weaker performance compared to the market, with specific indices declining [3][4] - The Shenwan Cosmetics Index fell by 2.6%, while the Shenwan Personal Care Index decreased by 0.6% [4][6] Upcoming Events - The Double 11 shopping festival preparations are in full swing, with domestic brands like Up Beauty and Proya launching new products to capture market share [9] - Key influencers are negotiating promotional strategies to enhance sales during the festival [9] Company Focus: Water Sheep Co., Ltd. - Water Sheep Co., Ltd. is positioned as a leading tech-driven beauty company with a stable revenue forecast and improving profit margins [10][11] - The company has a well-structured brand matrix and is expanding its high-end product lines, with significant growth in its proprietary brands [11][12] - Expected net profits for Water Sheep Co., Ltd. are projected to be 258 million, 331 million, and 398 million yuan for 2025, 2026, and 2027, respectively, indicating substantial growth [14] Market Trends - The Chinese beauty market is witnessing a shift towards domestic brands, with significant market share gains for local players [27] - The overall retail sales of cosmetics showed a growth of 5.1% in August 2025, indicating a recovery in consumer spending [18][21] International Recognition - Chinese beauty brands performed notably at the IFSCC conference, showcasing their advancements in cosmetic science and securing significant awards [22][24]

Investment Rating - The report maintains an "Overweight" rating for the industry, with a focus on new consumption sectors such as beauty care, IP derivatives, and gold jewelry [5][28]. Core Insights - The report highlights significant market movements, with the retail trade, social services, and beauty care sectors showing varied performance, ranking 19th, 27th, and 25th respectively among 31 primary industries during the week of September 8-12, 2025 [14][16]. - Key events include Huaxi Biological's strategic investment in Saint Pharma, which focuses on small nucleic acid drugs, and Jinbo Biological's approval for a new injectable collagen product [3][23]. - The report notes a substantial increase in domestic and international flight searches ahead of the Mid-Autumn Festival and National Day holidays, indicating a recovery in travel demand [4][24]. Summary by Sections 1. Weekly Market Review - The retail trade sector increased by 0.85%, while social services and beauty care sectors decreased by 0.28% and 0.23% respectively, compared to the Shanghai Composite Index's increase of 1.52% [14][16]. 2. Key Industry Data and News - The Chinese government allocated 100 billion yuan for childcare subsidies and plans to gradually implement free preschool education [3][23]. - Huaxi Biological invested approximately 138 million HKD in Saint Pharma, acquiring a 9.44% stake, while Jinbo Biological's new collagen product is the first of its kind to enter the pharmaceutical excipient market [23][24]. 3. Key Company Announcements - Jinbo Biological announced management changes, with founder Yang Xia appointed as CEO, and plans for a cash acquisition by Langzi Co. for a controlling stake in a cosmetic surgery hospital [27][28]. 4. Investment Recommendations - The report recommends focusing on companies such as Shangmei Co., Juzi Biological, and Marumi Biological, among others, as potential investment opportunities in the beauty care and new consumption sectors [5][28].